[
  {
    "ts": "2025-09-18T13:17:00+00:00",
    "headline": "Biogen Gets EU Nod for First Postpartum Depression Drug",
    "summary": "BIIB secures EU approval for Zurzuvae, the first oral treatment for postpartum depression, boosting its long-term growth prospects.",
    "url": "https://finance.yahoo.com/news/biogen-gets-eu-nod-first-131700385.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9b579e19-f451-38bf-ab34-1ed1c6491200",
      "content": {
        "id": "9b579e19-f451-38bf-ab34-1ed1c6491200",
        "contentType": "STORY",
        "title": "Biogen Gets EU Nod for First Postpartum Depression Drug",
        "description": "",
        "summary": "BIIB secures EU approval for Zurzuvae, the first oral treatment for postpartum depression, boosting its long-term growth prospects.",
        "pubDate": "2025-09-18T13:17:00Z",
        "displayTime": "2025-09-18T13:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507",
          "originalWidth": 620,
          "originalHeight": 496,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FrubqPEJ5SQTnAyfM_xUDw--~B/aD00OTY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507.cf.webp",
              "width": 620,
              "height": 496,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CQa3fKpJjXlLKWCIXJxJDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biogen-gets-eu-nod-first-131700385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-gets-eu-nod-first-131700385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T11:40:00+00:00",
    "headline": "Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates",
    "summary": "Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx™ has the potential to be a new, convenient way to administer medicines to patients living with neurological disorders. CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therape",
    "url": "https://finance.yahoo.com/news/biogen-acquire-alcyone-therapeutics-expanding-114000076.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "11e5cc04-4d4e-3c20-8f71-f9810168ae7d",
      "content": {
        "id": "11e5cc04-4d4e-3c20-8f71-f9810168ae7d",
        "contentType": "STORY",
        "title": "Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates",
        "description": "",
        "summary": "Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx™ has the potential to be a new, convenient way to administer medicines to patients living with neurological disorders. CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therape",
        "pubDate": "2025-09-18T11:40:00Z",
        "displayTime": "2025-09-18T11:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d8db71a830aa632e702f24ebd736c00d",
          "originalWidth": 865,
          "originalHeight": 290,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IDD9DHtEaM8wc.4J0e2kkA--~B/aD0yOTA7dz04NjU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d8db71a830aa632e702f24ebd736c00d.cf.webp",
              "width": 865,
              "height": 290,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iODOrgJZ_MV95T9B.jt0vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d8db71a830aa632e702f24ebd736c00d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biogen-acquire-alcyone-therapeutics-expanding-114000076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-acquire-alcyone-therapeutics-expanding-114000076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "IONS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T11:30:23+00:00",
    "headline": "Biogen’s Zurzuvae approved as first postpartum depression drug in Europe",
    "summary": "The postpartum depression marketing authorisation in the EU follows approvals for the drug in the US and the UK over the past two years.",
    "url": "https://www.pharmaceutical-technology.com/news/biogens-zurzuvae-approved-as-first-postpartum-depression-drug-in-europe/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "d8dbc8c7-f5f2-36fd-8c1e-46a0fc0576f4",
      "content": {
        "id": "d8dbc8c7-f5f2-36fd-8c1e-46a0fc0576f4",
        "contentType": "STORY",
        "title": "Biogen’s Zurzuvae approved as first postpartum depression drug in Europe",
        "description": "",
        "summary": "The postpartum depression marketing authorisation in the EU follows approvals for the drug in the US and the UK over the past two years.",
        "pubDate": "2025-09-18T11:30:23Z",
        "displayTime": "2025-09-18T11:30:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/e8535d1e87c97fbdfeb23d875e07f02b",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l7z5SyFT_XzxX_ROEwpMaw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/e8535d1e87c97fbdfeb23d875e07f02b.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h7l2ViPp9ykj58RFpaIvEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/e8535d1e87c97fbdfeb23d875e07f02b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/biogens-zurzuvae-approved-as-first-postpartum-depression-drug-in-europe/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-zurzuvae-approved-first-postpartum-113023944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T11:07:00+00:00",
    "headline": "Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs",
    "summary": "The purchase gives Biogen full access to an implantable device that could help patients avoid the repeat lumbar punctures required for drugs like Spinraza.",
    "url": "https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "a42626cc-c799-3d81-960c-ca966f939c55",
      "content": {
        "id": "a42626cc-c799-3d81-960c-ca966f939c55",
        "contentType": "STORY",
        "title": "Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs",
        "description": "",
        "summary": "The purchase gives Biogen full access to an implantable device that could help patients avoid the repeat lumbar punctures required for drugs like Spinraza.",
        "pubDate": "2025-09-18T11:07:00Z",
        "displayTime": "2025-09-18T11:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/d540900dfeca05c4e916670bf3cce9f7",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wx3rE.9wl4ShzTP7GuSpyA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/d540900dfeca05c4e916670bf3cce9f7.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pH1Ru4NmtB2PTC74KQ6_WA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/d540900dfeca05c4e916670bf3cce9f7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-buy-startup-alcyone-eyeing-110700700.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "IONS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]